About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Transcranial Pulse Stimulation for Depression | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05551585

Transcranial Pulse Stimulation for Depression

Transcranial pulse stimulation (TPS) is a newly developed brain stimulation therapy from Austria \& Germany with highly promising applicability in neuropsychiatric disorders. Major depressive disorder...

Lead sponsor: The Hong Kong Polytechnic University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

The Hong Kong Polytechnic University

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•MDD group
•Age 18 to 65;
•A clinical diagnosis of a MDD according to psychiatrist visit records or a clinical interview using the Chinese version of the Mini International Neuropsychiatric Interview (MINI)
•Baseline HAMD17 score ≥ 14;
•Treatment naivety or stable (≥4 weeks) psychopharmacological medication.

Exclusion Criteria

•Severe internal diseases including blood clotting disorders;
•Neurological disorders including bleeding prone micro-pathologies or a history of severe head injuries;
•Current psychiatric comorbidities, including addiction;
•Pregnancy;

Related studies

RECRUITINGPhase 4

Establishing Mobile Transcranial Magnetic Stimulation

NCT06748209 · Treatment Resistant Major Depression

University of Iowa Interventional Psychiatry Service Patient Registry

NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more

Study of Sleep Inertia in Major Depressive Disorder by the Psychomotor Vigilance Task

NCT06732284 · Major Depression, Sleep Inertia

Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project

NCT02434393 · Major Depression, Late Life Depression (LLD)

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

NCT07031817 · Bipolar Disorder (BD), Major Depressive Episode (MDE), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 24, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment80

Start dateJun 2023

Last updatedDec 24, 2025

Condition

Major Depression

Locations shown

The Hong Kong Polytechnic University

Hong Kong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 24, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions